Improve Osteoarthritis Care
Primary Purpose
Osteoarthritis, Knee, Osteoarthritis, Hip
Status
Enrolling by invitation
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Implementation of treatment guidelines
Sponsored by
About this trial
This is an interventional treatment trial for Osteoarthritis, Knee focused on measuring Implementation, Treatment guidelines
Eligibility Criteria
Inclusion Criteria:
- Self-reported hip or knee osteoarthritis
Exclusion Criteria:
- Persons who do not understand the Norwegian language
Sites / Locations
- Diakonhjemmet Hospital
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Pre and post implementation phases
Arm Description
Pre-implementation phase: during the pre-implementation period persons with hip or knee osteoarthritis will receive "usual care" as it is currently delivered by physiotherapists and general practitioners. Post-implementation phase: during the post-implementation phase patients with hip and knee OA will receive OA care more in line with the treatment recommendations.
Outcomes
Primary Outcome Measures
The OsteoArthritis Quality Indicator questionnaire (OA-QI), version 2
Assess change in patient-reported quality of OA care (mean total pass rate, 0-100 (best score))
Secondary Outcome Measures
Full Information
NCT ID
NCT04670549
First Posted
December 10, 2020
Last Updated
March 5, 2023
Sponsor
Diakonhjemmet Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04670549
Brief Title
Improve Osteoarthritis Care
Official Title
The Improve Osteoarthritis Care Study
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
November 13, 2020 (Actual)
Primary Completion Date
February 9, 2023 (Actual)
Study Completion Date
December 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Diakonhjemmet Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of The Improve Osteoarthritis Care study is to improve the quality of osteoarthritis care in Norwegian primary care, by increasing the use of recommended treatment modalities and improving patient access to recommended treatments. The study will use tailored implementation strategies, targeting primary care physicians and physiotherapists to improve knowledge and addressing individual barriers to providing recommended treatments.
Detailed Description
Previous research has shown that current osteoarthritis care for persons with hip or knee osteoarthritis (OA) in Norway has a potential for improvement as the provided care may not necessarily reflect evidence-based guideline recommendations. The overall purpose of the "Improve Osteoarthritis Care" study is that people with symptomatic hip and knee OA should receive care in line with current recommendations. To achieve this goal, tailored implementation strategies will be applied in order to: 1) Improve the quality of care offered to people with symptomatic hip and knee OA, 2) increase knowledge of recommended OA care among people with hip and knee OA, 3) Increase the number of primary care physiotherapists' offering group-based patient-education and structured exercise as part of their routine clinical practice, 4) Increase the number of general practitioners who have received a summary of the OA treatment recommendations.
To evaluate the effect of the tailored implementation strategy a pre-post design will be applied, and members of the Norwegian Rheumatology Association with self-reported hip or knee OA will be asked to evaluate quality of OA care at the two timepoints.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Knee, Osteoarthritis, Hip
Keywords
Implementation, Treatment guidelines
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Pre-post design
Masking
None (Open Label)
Allocation
N/A
Enrollment
1400 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Pre and post implementation phases
Arm Type
Other
Arm Description
Pre-implementation phase: during the pre-implementation period persons with hip or knee osteoarthritis will receive "usual care" as it is currently delivered by physiotherapists and general practitioners.
Post-implementation phase: during the post-implementation phase patients with hip and knee OA will receive OA care more in line with the treatment recommendations.
Intervention Type
Other
Intervention Name(s)
Implementation of treatment guidelines
Intervention Description
To improve knowledge of OA treatment recommendations among people with hip and knee OA, a lay language summary will be emailed all OA patient participants. A second summary of the treatment recommendations, targeting general practitioners (GPs) will also be emailed the OA patient participants. The patients will be encouraged to print and bring this summary to their GP at the next visit (user-initiated implementation). Barriers and facilitators for providing evidence-based OA care among primary care physiotherapists will be mapped through interviews. Thereafter, a tool-kit of strategies and practical aids intended to help overcome these barriers will be developed and made available for the physiotherapists.
Primary Outcome Measure Information:
Title
The OsteoArthritis Quality Indicator questionnaire (OA-QI), version 2
Description
Assess change in patient-reported quality of OA care (mean total pass rate, 0-100 (best score))
Time Frame
18 months follow-up
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Self-reported hip or knee osteoarthritis
Exclusion Criteria:
Persons who do not understand the Norwegian language
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nina Østerås
Organizational Affiliation
Diakonhjemmet Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Diakonhjemmet Hospital
City
Oslo
ZIP/Postal Code
0319
Country
Norway
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Improve Osteoarthritis Care
We'll reach out to this number within 24 hrs